Entera Bio Ltd. (NASDAQ:ENTX)
Insiders here have filed 5 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
No revenue reported, so there is no margin to score.
- Revenue
- $0
- Net income
- -$17.0M
- Net margin
- —
Little or no net debt.
- Total debt
- $425K
- Cash
- $11.3M
- Debt / equity
- 0.06
Comfortably covers what is due within a year.
- Current assets
- $18.9M
- Current liabilities
- $2.1M
- Current ratio
- 8.98
Consumes cash and must keep raising it.
- Operating cash flow
- -$11.3M
- Free cash flow
- -$11.4M
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 50.5M
- Share growth (1y)
- 7.7%
- Cash runway
- 12 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
ENTX Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 42.00 K |
| Revenue Growth (YoY) | — | -100.00 % | -100.00 % | -100.00 % | -100.00 % | — |
| Cost of Revenue | 0.00 | 7.00 K | 0.00 | 8.00 K | 0.00 | 42.00 K |
| Gross Profit | 0.00 | -7.00 K | 0.00 | -8.00 K | 0.00 | 0.00 |
| SG&A Expense | 1.36 M | 1.29 M | 1.32 M | 1.61 M | 1.15 M | 1.44 M |
| R&D Expense | 3.20 M | 2.24 M | 1.72 M | 1.64 M | 1.52 M | 1.12 M |
| Operating Expenses | 4.56 M | 3.53 M | 3.04 M | 3.25 M | 2.67 M | 2.56 M |
| Operating Income | -4.56 M | -3.54 M | -3.04 M | -3.26 M | -2.67 M | -2.56 M |
| Pretax Income | -7.31 M | -3.50 M | -3.02 M | -3.20 M | -2.66 M | -2.57 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -7.31 M | -3.50 M | -3.02 M | -3.20 M | -2.66 M | -2.57 M |
| EPS (Basic) | -0.14 | -0.07 | -0.07 | -0.07 | -0.06 | -0.06 |
| EPS (Diluted) | -0.14 | -0.07 | -0.07 | -0.07 | -0.06 | -0.06 |
| Shares Outstanding | 50.45 M | 47.76 M | 46.19 M | 47.09 M | 46.84 M | 43.38 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.